insights_auto
Why is DXCM down 3.42%?
Dive Deeperchevron_right
DXCM:NASDAQ
DexCom Inc
$83.93
arrow_downward
-3.42%(-2.97) 1D
Oct 6, 1:06:13 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DXCM...
Open
$86.28
High
$86.75
Low
$83.82
Mkt. cap
31.14B
Avg. vol.
3.80M
Volume
1.09M
P/E ratio
33.34
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
Open
$86.28
High
$86.75
Low
$83.82
Mkt. cap
31.14B
Avg. vol.
3.80M
Volume
1.09M
P/E ratio
33.34
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
News stories
From web sources and news partners
Yahoo! Finance Canada
·
3 hours ago
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading
Benzinga
·
22 hours ago
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
AD HOC NEWS
·
3 months ago
Dexcom Inc. stock pre-market at EUR 77.60: plus 0.52 percent
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com